⌘K
t
ImmuPharma PLC announced on 04 December 2024 the appointment of Ashley Clarke ACA as Company Secretary. This appointment took immediate effect from 03 December 2024. Ashley Clarke ACA also serves as the Group CFO for the company.
| Date | 4 Dec 2024 |
| Time | 07:00:07 |
| Category | Board changes |
| ID | 4674O |
3 December 2024
ImmuPharma PLC
("ImmuPharma" or the "Company")
Appointment of Company Secretary
ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, is pleased to confirm the appointment of Ashley Clarke ACA, as Company Secretary to the Company. The appointment is with immediate effect.
Ashley has been closely involved with the Company's accounts for several years via outsourced accountants, providing her with deep familiarity with ImmuPharma's operations. Now, as Group CFO, she is poised to leverage her extensive knowledge to drive strategic financial growth and ensure continued robust fiscal management. (More details on Ashley in 'Notes to Editors').
Ends
This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation no 596/2014 which is part of English law by virtue of the European (withdrawal) Act 2018, as amended. On publication of this announcement via a regulatory information service, this information is considered to be in the public domain.
|
For further information please contact:
|
Notes to Editors
About ImmuPharma PLC
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company's portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140,is a first-in class "immune tolerance restorer" for the treatment of SLE (Systemic Lupus Erythematosus) and CIDP (Chronic Idiopathic Demyelinating Polyneuropathy) and preclinical models suggest therapeutic activity for many other autoimmune diseases that share the same mechanism of action.
For additional information about ImmuPharma please visit www.immupharma.co.uk
ImmuPharma's LEI (Legal Entity Identifier) code : 213800VZKGHXC7VUS895.
Ashley Clarke ACA
Ashley has over a decade of experience in the financial sector, moving from a career in auditing, where she developed expertise working with a diverse portfolio of audit and non-audit clients across various industries. Ashley's experience spans from supporting SMEs to managing large international group consolidations, giving her a comprehensive understanding of financial management across different business scales.